Poolbeg Pharma wins UK regulatory clearance for cancer immunotherapy trial

Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF), the AIM-listed clinical-stage biopharmaceutical company, has received clinical trial authorisation from...